Boston Scientific to acquire Silk Road Medical for $1.2bn to enhance stroke prevention capabilities
Boston Scientific Corporation (NYSE: BSZ) has announced its definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for $27.50 per share, reflecting an enterprise value of approximately $1.16 billion. This transaction, which is a 38% premium over the volume-weighted average share price of Silk Road Medical’s stock over the past 60 days, is expected […]